Avitar Inc. | Income Statement

Fiscal year is October-September. All values USD Thousands.
2003
2004
2005
2006
2007
Sales/Revenue
4,598.00
4,048.50
4,508.90
4,924.80
3,106.20
Cost of Goods Sold (COGS) incl. D&A
3,433.10
2,713.10
3,182.80
3,504.20
2,269.50
Gross Income
1,164.90
1,335.40
1,326.10
1,420.50
836.70
SG&A Expense
4,368.00
3,965.60
5,053.60
4,449.80
3,569.50
Unusual Expense
-
66.00
100.00
138.10
-
Non Operating Income/Expense
16.70
561.40
1,618.20
876.90
1,966.70
Interest Expense
1,747.50
264.30
223.90
1,532.70
1,436.30
Pretax Income
4,933.90
2,399.10
2,433.20
3,823.20
2,202.40
Consolidated Net Income
4,933.90
2,399.10
2,433.20
3,823.20
2,202.40
Net Income
4,933.90
2,399.10
2,433.20
3,823.20
2,202.40
Net Income After Extraordinaries
3,372.10
2,386.30
2,433.20
3,943.20
2,145.10
Net Income Available to Common
6,608.30
4,259.70
4,776.20
3,985.20
2,354.40
EPS (Basic)
6.00
2.00
1.50
0.80
0.09
Basic Shares Outstanding
1,369.00
2,133.20
3,115.60
4,850.60
26,479.20
EPS (Diluted)
5.97
2.00
1.53
0.80
0.09
Diluted Shares Outstanding
1,369.00
2,133.20
3,115.60
4,850.60
26,479.20
EBITDA
3,034.00
2,514.00
3,580.10
2,885.60
2,614.10
Preferred Dividends
1,674.50
1,860.60
2,343.10
162.00
152.00

About Avitar

View Profile
Address
65 Dan Road
Canton Massachusetts 02021
United States
Employees -
Website -
Updated 07/08/2019
Avitar, Inc. develops, manufactures, markets and sells diagnostic test products. It manufactures and markets proprietary hydrophilic polyurethane foam disposables fabricated for medical, diagnostics, dental and consumer use. It also sells its products and services to employers, diagnostic test distributors, large medical supply companies, governmental agencies, and corporations.